These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9855483

  • 1. Production of serotonin syndrome by 8-OH DPAT in Cryptotis parva.
    Darmani NA, Zhao W.
    Physiol Behav; 1998 Nov 15; 65(2):327-31. PubMed ID: 9855483
    [Abstract] [Full Text] [Related]

  • 2. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA, Reeves SL.
    Pharmacol Biochem Behav; 1996 Sep 15; 55(1):1-10. PubMed ID: 8870031
    [Abstract] [Full Text] [Related]

  • 3. The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.
    Reissig CJ, Eckler JR, Rabin RA, Rice KC, Winter JC.
    Pharmacol Biochem Behav; 2008 Jan 15; 88(3):312-7. PubMed ID: 17936346
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 15; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 5. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
    Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG.
    Eur J Pharmacol; 1990 Feb 13; 176(3):331-40. PubMed ID: 1970304
    [Abstract] [Full Text] [Related]

  • 6. Role of 5-HT(1A)- and 5-HT(2A) receptors for the murine model of the serotonin syndrome.
    Haberzettl R, Fink H, Bert B.
    J Pharmacol Toxicol Methods; 2014 Feb 13; 70(2):129-33. PubMed ID: 25087754
    [Abstract] [Full Text] [Related]

  • 7. 5-HT1A receptor antagonists and lordosis behavior.
    Uphouse L, Andrade M, Caldarola-Pastuszka M, Jackson A.
    Neuropharmacology; 1996 Apr 13; 35(4):489-95. PubMed ID: 8793912
    [Abstract] [Full Text] [Related]

  • 8. Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.
    Fletcher PJ, Zeeb FD, Browne CJ, Higgins GA, Soko AD.
    Psychopharmacology (Berl); 2017 Mar 13; 234(5):889-902. PubMed ID: 28097374
    [Abstract] [Full Text] [Related]

  • 9. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Apr 13; 273(1):101-12. PubMed ID: 7714755
    [Abstract] [Full Text] [Related]

  • 10. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I, Ogren SO.
    Neuropsychopharmacology; 2000 Feb 13; 22(2):168-90. PubMed ID: 10649830
    [Abstract] [Full Text] [Related]

  • 11. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia.
    Bardin L, Tarayre JP, Koek W, Colpaert FC.
    Eur J Pharmacol; 2001 Jun 08; 421(2):109-14. PubMed ID: 11399266
    [Abstract] [Full Text] [Related]

  • 12. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA, Chou JM, Tang H, Frazer A.
    J Pharmacol Exp Ther; 1994 Jul 08; 270(1):198-208. PubMed ID: 8035316
    [Abstract] [Full Text] [Related]

  • 13. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, Gardier AM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):41-9. PubMed ID: 9650846
    [Abstract] [Full Text] [Related]

  • 14. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar 17; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 15. MKC-242, a novel 5-HT1A receptor agonist, facilitates cortical acetylcholine release by a mechanism different from that of 8-OH-DPAT in awake rats.
    Somboonthum P, Matsuda T, Asano S, Sakaue M, Baba A.
    Neuropharmacology; 1997 Mar 17; 36(11-12):1733-9. PubMed ID: 9517445
    [Abstract] [Full Text] [Related]

  • 16. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW, Ogilvie J, Houghton AK.
    Br J Pharmacol; 1997 Oct 17; 122(4):631-8. PubMed ID: 9375958
    [Abstract] [Full Text] [Related]

  • 17. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y, Kitagawa K, Fujitani Y, Shibata K, Araki H, Sendou T, Gomita Y.
    Biol Pharm Bull; 2007 Jan 17; 30(1):117-20. PubMed ID: 17202670
    [Abstract] [Full Text] [Related]

  • 18. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A, Li Q, Battaglia G, Van de Kar LD.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):261-6. PubMed ID: 9652368
    [Abstract] [Full Text] [Related]

  • 19. The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy.
    Gerber K, Filakovszky J, Halasz P, Bagdy G.
    Brain Res; 1998 Oct 05; 807(1-2):243-5. PubMed ID: 9757054
    [Abstract] [Full Text] [Related]

  • 20. 5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian gerbil.
    Eison AS, Wright RN.
    Pharmacol Biochem Behav; 1992 Sep 05; 43(1):131-7. PubMed ID: 1409796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.